Indefinite Delivery Contract SPE2DX15D9333
- Not listed
- The federal contract IDV award SPE2DX15D9334 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) under the TRICARE West program to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers...
- The federal contract IDV award SPE2DX15D9380 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and held by the woman-owned small business DMS Pharmaceutical Group Inc. The contract was awarded by the Defense Logistics Agency (DLA) under the TRICARE WEST program, with a period of performance from April 27, 2015 to December 31, 2025. Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to support the...
- The federal contract IDV award SPE2DX15D9387 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,999,999.00 IDC was awarded by the Defense Logistics Agency (DLA) under the TRICARE WEST program and is valid through December 31, 2025. Under this IDC, DMS Pharmaceutical Group Inc. provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical...
- The federal contract IDV award SPE2DX15D9335 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, valid through November 2026, was awarded by the Defense Logistics Agency (DLA) under the TRICARE WEST program to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare...
- This federal contract IDV award, SPM2DX14D0968, is a single-award indefinite delivery contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at up to $4,999,999, was awarded by the Defense Logistics Agency's Medical Supply Chain division to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide under the TRICARE West...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, with a ceiling value of $4,999,999.00 through December 2025. The contract enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities and veterans' medical centers under the TRICARE West program. The contract has a total ceiling value of $4,999,999 and a period of performance through December 31, 2025. It enables the DLA to issue firm...
- This indefinite delivery contract (IDC) was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award IDC, valued at up to $499,999,999, covers a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military healthcare facilities worldwide under the TRICARE West program. Through...
- The federal contract IDV award, SPM2DX14D0977, is an Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $4,999,999, was awarded by the Defense Logistics Agency (DLA) to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide under the Medical Supply Chain...
- The federal contract IDV award with ID SPE2DX15D9373 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The IDC covers an...
- SPE2DX15D9333Indefinite Delivery Contract
- 1Federal Contract Awards
The federal contract IDV award SPE2DX15D9333 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract was awarded by the Defense Logistics Agency (DLA) under the TRICARE WEST program to provide a comprehensive range of pharmaceutical products and medical supplies to military healthcare facilities nationwide. The IDC covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This enables the DLA to issue firm fixed-price delivery orders to support the recurring medical supply needs of the Department of Defense (DoD). The contract has an ultimate completion date of December 31, 2025 and does not utilize any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards. Under this IDC, a recent $182 firm fixed-price delivery order was issued in November 2021 to support the TRICARE WEST program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 4/27/15 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPE2DX15D9333-SPE2DX22FDZ51 | DMS Pharmaceutical Group Inc. | $182 | 11/19/21 | 11/30/21 | 11/19/21 |